FRANKFURT (Reuters) – The world’s biggest central banks may be on the verge of securing the holy grail of monetary policy: an economic soft landing, despite the sharpest interest rate …
grail
-
-
By Eric Onstad LONDON (Reuters) – Solid-state batteries hold the promise of more energy storage, longer driving ranges and faster charging for next-generation electric vehicles. Yet despite decades of research …
-
By Mike Scarcella (Reuters) – A U.S. appeals court on Tuesday said it will accelerate reviewing Illumina Inc’s challenge to a federal agency order requiring the biotechnology company to divest …
-
By Foo Yun Chee BRUSSELS (Reuters) -U.S. life sciences company Illumina is in talks with European Union antitrust regulators to divest Grail ahead of an expected EU veto next week …
-
(Reuters) – A judge has ruled in favor of Illumina Inc in its acquisition of Grail Inc dealing a blow to the U.S. Federal Trade Commission’s efforts to unwind the …
-
BRUSSELS – EU antitrust regulators are expected to veto U.S. life sciences firm Illumina’s acquisition of biotechnology company Grail, people familiar with the matter said on Wednesday. There are doubts …
-
By Foo Yun Chee LUXEMBOURG -U.S. life sciences company Illumina on Wednesday lost its challenge against European Union scrutiny of its $8 billion cash-and-stock takeover of Grail, as a top …
-
By Foo Yun Chee BRUSSELS – A European court will decide on July 13 whether U.S. life sciences company Illumina’s $8 billion cash-and-stock takeover of Grail should be scrutinised by …
-
By Foo Yun Chee LUXEMBOURG – U.S. life sciences company Illumina on Thursday criticised EU antitrust regulators for scrutinising its $8 billion cash-and-stock takeover of Grail even though the cancer detection test maker …